Cargando…
Inducible expression of interleukin-12 augments the efficacy of affinity-tuned chimeric antigen receptors in murine solid tumor models
The limited number of targetable tumor-specific antigens and the immunosuppressive nature of the microenvironment within solid malignancies represent major barriers to the success of chimeric antigen receptor (CAR)-T cell therapies. Here, using epithelial cell adhesion molecule (EpCAM) as a model an...
Autores principales: | Yang, Yanping, Yang, Huan, Alcaina, Yago, Puc, Janusz, Birt, Alyssa, Vedvyas, Yogindra, Gallagher, Michael, Alla, Srinija, Riascos, Maria Cristina, McCloskey, Jaclyn E., Du, Karrie, Gonzalez-Valdivieso, Juan, Min, Irene M., de Stanchina, Elisa, Britz, Matt, von Hofe, Eric, Jin, Moonsoo M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097865/ https://www.ncbi.nlm.nih.gov/pubmed/37045815 http://dx.doi.org/10.1038/s41467-023-37646-y |
Ejemplares similares
-
SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity
por: Alcaina, Yago, et al.
Publicado: (2022) -
Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy
por: Vedvyas, Yogindra, et al.
Publicado: (2019) -
Publisher Correction: Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy
por: Vedvyas, Yogindra, et al.
Publicado: (2020) -
Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer
por: Jung, Minkyu, et al.
Publicado: (2020) -
Micromolar affinity CAR T cells to ICAM-1 achieves rapid tumor elimination while avoiding systemic toxicity
por: Park, Spencer, et al.
Publicado: (2017)